Sofwave AI Stock Analysis
Want to see IL:SOFW full AI Analyst Report?
Sofwave (SOFW) AI Stock Analysis
Sofwave
(TASE:SOFW)
Sofwave (IL:SOFW) earns a strong overall score of 86, driven primarily by its stellar financial performance and robust technical momentum. The company has successfully scaled its top line while pivoting to substantial profitability and positive cash flow, all backed by an unlevered balance sheet. Technically, the stock is in a confirmed uptrend, trading above all major moving averages with healthy, bullish indicators. The primary offsetting factor is its valuation; a P/E ratio of 33.95 indicates a premium pricing that reflects its high-growth profile but presents a moderate valuation risk.
Sofwave (SOFW) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 1.34B
- Dividend Yield
- ―
- Average Volume (3M)
- 94.97K
- Price to Earnings (P/E)
- 32.0
- Beta (1Y)
- 0.67
- Revenue Growth
- 25.84%
- EPS Growth
- 1717.73%
- Country
- Israel
- Employees
- 151
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Sofwave Business Overview & Revenue Model
Company Description
Founded in 2015, Sofwave Medical Ltd. is an Israeli company dedicated to developing cutting-edge ultrasound technology. This technology is employed for the non-invasive treatment of fine lines and wrinkles, with the company's reach extending to physi...
Sofwave Financial Statement Overview
Summary
Sofwave demonstrates exceptional financial health across the board. The company has scaled revenue dramatically to $111.9 million in the TTM period while maintaining stellar 74-76% gross margins. It has successfully pivoted to profitability, generating $12.0 million in TTM net income and $14.9 million in free cash flow. A negligible debt-to-equity ratio of 0.03 and a highly impressive 32.4% return on equity highlight a pristine balance sheet and efficient capital use.
Income Statement
90Very PositiveBalance Sheet
92Very PositiveCash Flow
89Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.91M | 94.86M | 59.65M | 50.31M | 35.63M | 21.84M |
| Gross Profit | 85.01M | 70.27M | 45.34M | 37.48M | 26.33M | 16.24M |
| EBITDA | 15.70M | 9.39M | -2.19M | -6.61M | -17.55M | -6.43M |
| Net Income | 12.02M | 5.94M | -4.55M | -8.28M | -19.53M | -6.83M |
Balance Sheet | ||||||
| Total Assets | 65.99M | 55.78M | 43.03M | 43.54M | 46.08M | 60.77M |
| Cash, Cash Equivalents and Short-Term Investments | 30.88M | 35.28M | 21.62M | 24.42M | 32.01M | 46.22M |
| Total Debt | 1.25M | 1.12M | 1.40M | 1.33M | 1.92M | 2.37M |
| Total Liabilities | 23.37M | 23.06M | 18.50M | 17.19M | 13.74M | 14.07M |
| Stockholders Equity | 42.62M | 32.72M | 24.53M | 26.34M | 32.34M | 46.70M |
Cash Flow | ||||||
| Free Cash Flow | 14.92M | 14.51M | -2.67M | -6.71M | -11.14M | -2.92M |
| Operating Cash Flow | 15.69M | 15.08M | -2.40M | -6.31M | -10.69M | -2.10M |
| Investing Cash Flow | -10.74M | -1.15M | 254.00K | 409.00K | -260.00K | -982.00K |
| Financing Cash Flow | -77.98K | -469.79K | -620.00K | -1.72M | -1.35M | 46.64M |
Sofwave Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:SOFW, the sentiment is Positive. The current price of 3683.00 is above the 20-day moving average (MA) of 3619.35, above the 50-day MA of 3441.00, and below the 200-day MA of 3831.05, indicating a neutral trend. The MACD of 41.81 indicates Positive momentum. The RSI at 54.28 is Neutral, neither overbought nor oversold. The STOCH value of 34.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:SOFW.
Sofwave Peers Comparison
Overall Rating
IL:SOFW86Outperform
IL:BWAY70Outperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:SOFW | Sofwave Medical Ltd. | 3683.00 | 734.00 | 24.89% | |
| IL:BWAY | Brainsway | 2969.00 | 438.00 | 17.31% | |
| IL:ILX | ILEX Medical Ltd. | 4717.00 | -1849.73 | -28.17% | |
| IL:ALMD | Allmed Solutions Ltd. | 29.40 | -2.10 | -6.67% | |
| IL:EPIT | EPITOMEE MEDICAL LTD | 246.60 | -475.50 | -65.85% | |
| IL:PLSM | Pulsenmore | 464.20 | -1967.47 | -80.91% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026
